Synapse - Glenn Heller

Results (400)

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer

Journal Article

Scher, H. I.; Heller, G.; Molina, A.; Attard, G.; Danila, D. C.; Jia, X.; Peng, W.; Sandhu, S. K.; Olmos, D.; Riisnaes, R.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
Bone Marrow Transplantation (2015)

Fulltext@MSK | Save

KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation

Journal Article

Tarek, N.; Gallagher, M. M.; Chou, J. F.; Lubin, M. N.; Heller, G.; Barker, J. N.; Hsu, K. C.
Bone Marrow Transplantation (2015)

Fulltext@MSK | Save

Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)

Meeting Abstract

Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival

Journal Article

Danila, D. C.; Anand, A.; Schultz, N.; Heller, G.; Wan, M.; Sung, C. C.; Dai, C.; Khanin, R.; Fleisher, M.; Lilja, H.; more...
European Urology (2014)

Fulltext@MSK | Save

Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Journal Article

Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
Blood (2014)

Fulltext@MSK | Save

Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Risk assessment for severe hypocalcemia requiring hospitalization with denosumab

Meeting Abstract

Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer

Meeting Abstract

Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save